The best hope for coronavirus treatment is an experimental drug that fizzled against Ebola

Washington Post | Capital Business

Mar 11, 2020

Gilead's experimental therapy has been studied since 2014 with taxpayer support. Now it is being tested in clinical trials in China and elsewhere for coronavirus.